These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 29947493

  • 1. Clodronate in the management of different musculoskeletal conditions.
    Frediani B, Giusti A, Bianchi G, Dalle Carbonare L, Malavolta N, Cantarini L, Saviola G, Molfetta L.
    Minerva Med; 2018 Aug; 109(4):300-325. PubMed ID: 29947493
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CLODRONATE: OLD DRUG, NEW USES.
    Saviola G, Abdi-Ali L, Povino MR.
    J Biol Regul Homeost Agents; 2015 Aug; 29(3):719-22. PubMed ID: 26403413
    [Abstract] [Full Text] [Related]

  • 4. Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders.
    Ghinoi V, Brandi ML.
    Expert Opin Pharmacother; 2002 Nov; 3(11):1643-56. PubMed ID: 12437497
    [Abstract] [Full Text] [Related]

  • 5. Use of clodronate in the management of osteoarthritis: an update.
    Saviola G, Abdi-Ali L, Comini L, Dalle-Carbonare LG.
    J Biol Regul Homeost Agents; 2002 Nov; 33(5):1315-1320. PubMed ID: 31591875
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Bisphosphonates Clodronate and Etidronate Exert Analgesic Effects by Acting on Glutamate- and/or ATP-Related Pain Transmission Pathways.
    Shima K, Nemoto W, Tsuchiya M, Tan-No K, Takano-Yamamoto T, Sugawara S, Endo Y.
    Biol Pharm Bull; 2016 Nov; 39(5):770-7. PubMed ID: 27150146
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.
    Abitbol V, Briot K, Roux C, Roy C, Seksik P, Charachon A, Bouhnik Y, Coffin B, Allez M, Lamarque D, Chaussade S.
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1184-9. PubMed ID: 17683996
    [Abstract] [Full Text] [Related]

  • 12. Clodronate : a review of its use in the prevention of bone metastases and the management of skeletal complications associated with bone metastases in patients with breast cancer.
    Dando TM, Wiseman LR.
    Drugs Aging; 2004 Oct; 21(14):949-62. PubMed ID: 15554753
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
    Tuppurainen M, Härmä K, Komulainen M, Kiviniemi V, Kröger H, Honkanen R, Alhava E, Jurvelin J, Saarikoski S.
    Maturitas; 2010 Aug; 66(4):423-30. PubMed ID: 20547017
    [Abstract] [Full Text] [Related]

  • 16. Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].
    Powles T, Paterson A, McCloskey E, Schein P, Scheffler B, Tidy A, Ashley S, Smith I, Ottestad L, Kanis J.
    Breast Cancer Res; 2006 Aug; 8(2):R13. PubMed ID: 16542503
    [Abstract] [Full Text] [Related]

  • 17. Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates.
    Muratore M, Quarta E, Grimaldi A, Calcagnile F, Quarta L.
    Drug Des Devel Ther; 2011 Aug; 5():445-54. PubMed ID: 22087064
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic and tolerability of i.m. disodium clodronate 200 mg/lidocaine 1%, given twice monthly, in comparison with i.m. disodium clodronate 100 mg/lidocaine 1%, given weekly, in healthy postmenopausal female patients.
    Radicioni M, Cremonesi G, Baraldi E, Leuratti C, Mariotti F.
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):313-22. PubMed ID: 23357844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.